These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 27585789)
1. The role of Ly49E receptor expression on murine intraepithelial lymphocytes in intestinal cancer development and progression. Van Acker A; Louagie E; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Elewaut D; Taghon T; Vandekerckhove B; Plum J; Leclercq G Cancer Immunol Immunother; 2016 Nov; 65(11):1365-1375. PubMed ID: 27585789 [TBL] [Abstract][Full Text] [Related]
2. Differential Ly49e expression pathways in resting versus TCR-activated intraepithelial γδ T cells. Van Den Broeck T; Van Ammel E; Delforche M; Taveirne S; Kerre T; Vandekerckhove B; Taghon T; Plum J; Leclercq G J Immunol; 2013 Mar; 190(5):1982-90. PubMed ID: 23338239 [TBL] [Abstract][Full Text] [Related]
3. Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours. Filtjens J; Keirsse J; Van Ammel E; Taveirne S; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van Ginderachter JA; Leclercq G Sci Rep; 2016 Jul; 6():30564. PubMed ID: 27469529 [TBL] [Abstract][Full Text] [Related]
4. Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Van Den Broeck T; Stevenaert F; Taveirne S; Debacker V; Vangestel C; Vandekerckhove B; Taghon T; Matthys P; Plum J; Held W; Dewerchin M; Yokoyama WM; Leclercq G Blood; 2008 Dec; 112(13):5046-51. PubMed ID: 18784372 [TBL] [Abstract][Full Text] [Related]
5. Ly49E expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseases. Van Acker A; Filtjens J; Van Welden S; Taveirne S; Van Ammel E; Vanhees M; Devisscher L; Kerre T; Taghon T; Vandekerckhove B; Plum J; Leclercq G PLoS One; 2014; 9(10):e110015. PubMed ID: 25310588 [TBL] [Abstract][Full Text] [Related]
6. Mice lacking Ly49E show normal NK cell development and provide evidence for probabilistic expression of Ly49E in NK cells and T cells. Aust JG; Gays F; Hussain F; Butcher GW; Kist R; Peters H; Brooks CG J Immunol; 2011 Feb; 186(4):2013-23. PubMed ID: 21248256 [TBL] [Abstract][Full Text] [Related]
7. A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties. Van Acker A; Gronke K; Biswas A; Martens L; Saeys Y; Filtjens J; Taveirne S; Van Ammel E; Kerre T; Matthys P; Taghon T; Vandekerckhove B; Plum J; Dunay IR; Diefenbach A; Leclercq G Cell Rep; 2017 May; 19(7):1431-1443. PubMed ID: 28514662 [TBL] [Abstract][Full Text] [Related]
8. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682 [TBL] [Abstract][Full Text] [Related]
9. Expression of inhibitory receptors Ly49E and CD94/NKG2 on fetal thymic and adult epidermal TCR V gamma 3 lymphocytes. Van Beneden K; De Creus A; Stevenaert F; Debacker V; Plum J; Leclercq G J Immunol; 2002 Apr; 168(7):3295-302. PubMed ID: 11907085 [TBL] [Abstract][Full Text] [Related]
10. Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors. Stevenaert F; Van Beneden K; De Creus A; Debacker V; Plum J; Leclercq G J Leukoc Biol; 2003 Jun; 73(6):731-8. PubMed ID: 12773505 [TBL] [Abstract][Full Text] [Related]
12. Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice. Marsh L; Coletta PL; Hull MA; Selby PJ; Carding SR Int J Oncol; 2012 Jan; 40(1):243-50. PubMed ID: 21879254 [TBL] [Abstract][Full Text] [Related]
13. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784 [TBL] [Abstract][Full Text] [Related]
14. The Ly49E Receptor Inhibits the Immune Control of Acute Filtjens J; Coltel N; Cencig S; Taveirne S; Van Ammel E; Van Acker A; Kerre T; Matthys P; Taghon T; Vandekerckhove B; Carlier Y; Truyens C; Leclercq G Front Immunol; 2016; 7():472. PubMed ID: 27891126 [TBL] [Abstract][Full Text] [Related]
15. Abundant stage-dependent Ly49E expression by liver NK cells is not essential for their differentiation and function. Filtjens J; Taveirne S; Van Acker A; Van Ammel E; Vanhees M; Kerre T; Taghon T; Vandekerckhove B; Plum J; Leclercq G J Leukoc Biol; 2013 May; 93(5):699-711. PubMed ID: 23475576 [TBL] [Abstract][Full Text] [Related]
16. Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development. Filtjens J; Foquet L; Taveirne S; Van Ammel E; Vanhees M; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van den Steen PE; Leclercq G PLoS One; 2014; 9(1):e87463. PubMed ID: 24498110 [TBL] [Abstract][Full Text] [Related]
17. Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators. Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070 [TBL] [Abstract][Full Text] [Related]
18. Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Mutoh M; Teraoka N; Takasu S; Takahashi M; Onuma K; Yamamoto M; Kubota N; Iseki T; Kadowaki T; Sugimura T; Wakabayashi K Gastroenterology; 2011 Jun; 140(7):2000-8, 2008.e1-2. PubMed ID: 21334339 [TBL] [Abstract][Full Text] [Related]
19. Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion. Mahmoud AB; Tu MM; Wight A; Zein HS; Rahim MM; Lee SH; Sekhon HS; Brown EG; Makrigiannis AP PLoS Pathog; 2016 Feb; 12(2):e1005446. PubMed ID: 26928844 [TBL] [Abstract][Full Text] [Related]
20. Deoxycholic acid activates epidermal growth factor receptor and promotes intestinal carcinogenesis by ADAM17-dependent ligand release. Dong W; Liu L; Dou Y; Xu M; Liu T; Wang S; Zhang Y; Deng B; Wang B; Cao H J Cell Mol Med; 2018 Sep; 22(9):4263-4273. PubMed ID: 29956475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]